EPS

As OneSpan prepares its Q2 2026 report, the results will offer more than financial data; they will signal the health of the burgeoning digital trust economy.

With Q2 results pending, Howmet Aerospace faces a pivotal moment. Can its tech leadership and a new $1.8B acquisition keep it ahead in a turbulent market?

As Builders FirstSource prepares its Q2 2026 earnings call, investors are watching for signs of resilience in a market battered by high rates and slowing starts.

As INVH preps its Q2 report, all eyes are on its ability to merge tech-driven efficiency with market realities in America's tight single-family rental sector.

National Bank Holdings Corp. will soon reveal its Q2 results. We analyze the key metrics and strategic moves investors should be watching closely.

Monster's 2-for-1 split isn't just a technicality. It's a signal of confidence backed by record sales, diversification, and a strategy to fuel growth.

Honeywell Technologies' reverse stock split doubled its EPS guidance, but the real story isn't the new share price. It's the shrinking cash flow forecast.

With its stock lagging, Vermilion Energy renews a major share buyback, a defiant signal of undervaluation. Is this a savvy capital play or a bet against market headwinds?

As ONE Gas prepares to announce strong Q2 earnings, a closer look reveals a model where investor security is financed by rate hikes for 2.3 million customers.

AZZ reports record Q1 sales, defying mixed markets with operational strength. Raised guidance and a dividend hike signal confidence in the industrial economy.

Ultra Clean Holdings appoints Michael Keogh, a veteran of Ford's EV unit and Apple, as CFO to execute its UCT 3.0 strategy amid soaring AI chip demand.

PriceSmart posts strong Q3 sales but misses on earnings, unveiling a landmark expansion into Chile and deepening its Costa Rican footprint amid a dynamic LatAm market.

As Clean Harbors preps its Q2 earnings call, the results will offer more than numbers—they'll reveal the state of industrial resilience and environmental policy.

Calumet's $100M debt redemption is more than a fiscal cleanup; it's a calculated move to fuel innovation in renewable fuels and specialty chemicals.

After a clinical hold on its lead drug, Quantum BioPharma is spending heavily on marketing. Is it a bold play for survival or a sign of desperation?

After a rocky Q1, all eyes are on Pegasystems' upcoming results. Will its AI strategy pay off in a tough market, or are more headwinds ahead?

Business First Bancshares' latest deal is more than an acquisition; it's the creation of a one-stop advisory hub for a community banking sector in flux.

As First Industrial Realty Trust preps its Q2 report, its performance is more than numbers—it's a barometer for supply chain resilience and market discipline.

With its stock at an all-time high after a stellar Q1, all eyes are on Univest's upcoming Q2 report to see if its strategic execution can defy market pressures.